Experience

Stibbe advises on the equity offering of ProQR

Stibbe advises on the equity offering of ProQR

Stibbe advises on the equity offering of ProQR

10.09.2018 NL law

Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR"). 

ProQR is a biopharmaceutical company creating transformative RNA medicines for the treatment of severe genetic rare diseases and listed on Nasdaq.

Team

Related experience

This website uses cookies. Some of these cookies are essential for the technical functioning of our website and you cannot disable these cookies if you want to read our website. We also use functional cookies to ensure the website functions properly and analytical cookies to personalise content and to analyse our traffic. You can either accept or refuse these functional and analytical cookies.

Privacy – en cookieverklaring